About Tychos Therapeutics
Tychos Therapeutics is a Healthcare company based in India founded in 2018. It specializes in RD and manufacturing of drugs across multiple therapeutic areas. It operates on a B2B model. The company has 12 employees. Its Indian entity Tychos Therapeutics Private Limited reported revenue of ₹7.74 Cr. Its focus areas include Pharmaceuticals, Drug Manufacturing and R&D and Therapeutics. Similar companies include Akums, Jubilant Life Sciences and Nectar Lifesciences; 2 of its 3 listed similar companies have raised funding.
Company details
Tychos Therapeutics, established in 2018, excels in providing healthcare solutions, producing pharmaceutical products, drug manufacturing, and rd and therapeutics. Specializes in RD and manufacturing of drugs across multiple therapeutic areas. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide.
- Headquarters India
- Employees 12
- SectorsHealthcare
- Website tychos.in
- Legal Name Tychos Therapeutics Private Limited
- Date of Incorporation 15 Dec, 2003
- Jurisdiction Chennai, Tamil Nadu, India
- Annual Revenue₹7.74 Cr
FY 2024 · -4% YoY
- Net Profit₹17.4 Lakh
FY 2024 · 2% margin
- EBITDA₹77.2 Lakh
FY 2024 · 10% margin
- Employee Count12
Associated legal entities of Tychos Therapeutics
Tychos Therapeutics operates through Tychos Therapeutics Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Tychos Therapeutics Private Limited CIN U51397TN2003PTC052144 | Active | 15 Dec 2003 | Chennai, Tamil Nadu | ₹7.7 Cr | 12 | 2 | View details |
Board of directors of Tychos Therapeutics Private Limited (Tychos Therapeutics)
Tychos Therapeutics Private Limited is the primary company behind Tychos Therapeutics. The board of Tychos Therapeutics Private Limited currently have 2 directors; the longest-serving is Maniyan Elangovan, appointed in 2003. 3 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Maniyan Elangovan DIN 02126286 | Managing Director | 15 Dec 2003 | 22 yrs 10 mo | Tychos Therapeutics Private Limited |
| Sunitha Nagarajan DIN 02418071 | Director | 04 Mar 2013 | 13 yrs 8 mo | Tychos Therapeutics Private Limited |
Financials of Tychos Therapeutics
Figures of Tychos Therapeutics Private Limited, the primary company behind Tychos Therapeutics, for FY 2024. Revenue was ₹7.74 Cr (-4% year on year). Net profit was ₹17.4 Lakh (2% margin). EBITDA was ₹77.2 Lakh (10% margin). Revenue has grown at a compounded annual rate of -4% over three years and -1% over five years.
- ₹7.74 CrRevenue · FY 2024 · -4% YoY
- ₹17.4 LakhNet profit · 2% margin
- ₹77.2 LakhEBITDA · 10% margin
- ₹36 LakhPaid-up capital
- 12Employees (provident fund records)
- -4%Revenue CAGR, 3 years
- -1%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Tychos Therapeutics Private Limited are on its company page.
Detailed financial statements for Tychos Therapeutics
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Tychos Therapeutics
Tychos Therapeutics has 3 listed similar companies in our database, 2 of them funded. They include Akums, Jubilant Life Sciences and Nectar Lifesciences.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| akums.in | 2004 | Delhi, India | $70M | 395 | CDMO focusing on spectrum of dosage forms and therapeutic segments | |
| jubl.com | 1978 | Noida, India | Company offering a suite of R&D and manufacturing services for small molecules and generics | |||
| neclife.com | 1995 | Chandigarh, India | $46.85M | 175 | Cephalosporin APIs and generic formulations are manufactured. |
Detailed similar companies of Tychos Therapeutics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Tychos Therapeutics
Tychos Therapeutics was founded in 2018.
Tychos Therapeutics is headquartered in India.
Tychos Therapeutics has 12 employees.
The primary company behind Tychos Therapeutics, Tychos Therapeutics Private Limited, reported revenue of ₹7.74 Cr for FY 2024, down 4% year on year.
Tychos Therapeutics, established in 2018, excels in providing healthcare solutions, producing pharmaceutical products, drug manufacturing, and rd and therapeutics. Specializes in RD and manufacturing of drugs across multiple therapeutic areas. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide.
Tychos Therapeutics's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.
Tychos Therapeutics operates through Tychos Therapeutics Private Limited.
The legal entities of Tychos Therapeutics currently have 2 directors, including Maniyan Elangovan, Sunitha Nagarajan.